▼ -3.34% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Cronos Group in the last 3 months. The average price target is $8.19, with a high forecast of $11.00 and a low forecast of $5.00. The average price target represents a -3.34% upside from the last price of $8.47.
The current consensus among 8 investment analysts is to hold stock in Cronos Group. This Hold consensus rating has held steady for over two years.
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.